Disease Info Card

Esophageal Motility Disorders

Information about Esophageal Motility Disorders: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Esophageal Motility Disorders

Most recent studies have shown that Esophageal Motility Disorders shares some biological mechanisms with chest-pain, crest-syndrome, deglutition-disorders, diffuse-scleroderma, esophageal-achalasia, esophageal-diseases, esophageal-spasm, esophagitis, gastroesophageal-reflux-disease, heartburn, hiatal-hernia, nutcracker-esophagus, pain, pathological-dilatation, raynaud-disease, scleroderma, sclerosis, spasm, stenosis, telangiectasis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Esophageal Motility Disorders, and have been seen in publications frequently: Acid Secretion, Aging, Anaphase, Gastric Acid Secretion, Gastric Emptying, Gastric Motility, Hypersensitivity, Innervation, Metaphase, Muscle Contraction, Pathogenesis, Peristalsis, Prophase, Reflex, Response To Acid, Rumination, Secretion, Sensitization, Transport, Transposition

Quite a number of genes have been found to play important roles in Esophageal Motility Disorders, such as CALR, CDSN, CENPA, CENPB, ELANE, EXOSC10, FUT2, GNAI1, GNL3, IL6, KRAS, SLC17A5, SQLE, SS18L1, SSB, TAC1, TEF, VIP. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.